---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-050365"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T06:07:39.291902+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nektar shareholders elect three directors, approve 8M share increase, ratify auditor

## Summary
- Elected directors Jeff Ajer, Robert B. Chess, Roy A. Whitfield with broker non-votes of 46.7M each.
- Approved amendment to 2017 Performance Incentive Plan adding 8M shares; 86.5M for, 7.5M against.
- Ratified Ernst & Young as independent auditor for FY2024: 139M for, 1.6M against, 6M abstain.
- Non-binding say-on-pay approved: 87M for, 6.7M against, 6.2M abstain.

## SEC filing metadata
- accession: 0001213900-24-050365
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390024050365/0001213900-24-050365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390024050365/ea0207441-8k_nektar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-050365
- JSON: https://secwatch.observer/filing/0001213900-24-050365.json
- Plain text: https://secwatch.observer/filing/0001213900-24-050365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.